Skip to main content

Advertisement

SpringerLink
Log in

Intrahepatic cholestasis of pregnancy

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

Intrahepatic cholestasis of pregnancy (or obstetric cholestasis) is a liver disorder that occurs in late pregnancy. Despite the potential adverse maternal and fetal/neonatal outcomes, cholestasis of pregnancy is often neglected and treated expectantly. More research is needed to improve the molecular and genetic understanding of the disease and to define a safe and effective medical treatment that improves clinical outcome. Ursodeoxycholic acid is considered to be a safe treatment option in the third trimester, but further randomized controlled trials are needed before ursodeoxycholic acid treatment can be generally recommended. Ursodeoxycholic acid is preferentially administered to patients with severe cholestasis (onset before week 33 or serum bile acid levels > 70 mmol/L) or to patients with a history of sudden fetal death, while maintaining close obstetric and regular biochemical surveillance (transaminases, bilirubin, and bile acid levels). Ursodeoxycholic acid can decrease pruritus and ameliorate liver tests, but effects on obstetric complications are ambiguous. S-Adenosylmethionine, dexamethasone, and cholestyramine can provide some relief of itching. Because none of these drugs have been shown to be harmful to mother or fetus, the individual woman and her clinician may decide whether to try one of the treatments described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Lammert F, Marschall HU, Glantz A, Matern S: Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000, 33:1012–1021.

    Article  PubMed  CAS  Google Scholar 

  2. Rioseco AJ, Ivankovic MB, Manzur A, et al.: Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994, 170:890–895.

    PubMed  CAS  Google Scholar 

  3. Davies MH, da Silva RC, Jones SR, et al.: Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 1995, 37:580–584.

    PubMed  CAS  Google Scholar 

  4. Gaudet R, Merviel P, Berkane N, et al.: Fetal impact of cholestasis of pregnancy: experience at Tenon Hospital and literature review. Fetal Diagn Ther 2000, 5:191–197.

    Article  Google Scholar 

  5. Kenyon AP, Piercy CN, Girling J, et al.: Pruritus may precede abnormal liver function tests in pregnant women with obstetric cholestasis: a longitudinal analysis. B J Obstet Gynaecol 2001, 108:1190–1192.

    Article  CAS  Google Scholar 

  6. Bacq Y: Intrahepatic cholestasis of pregnancy. Clin Liver Dis 1999, 3:1–13.

    Article  Google Scholar 

  7. Rodrigues CM, Marin JJ, Brites D: Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment. Gut 1999, 45:446–452.

    Article  PubMed  CAS  Google Scholar 

  8. Macias RI, Pascual MJ, Bravo A, et al.: Effect of maternal cholestasis on bile acid transfer across the rat placentamaternal liver tandem. Hepatology 2000, 31:975–983.

    Article  PubMed  CAS  Google Scholar 

  9. Serrano MA, Brites D, Larena MG, et al.: Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol 1998, 28:829–839.

    Article  PubMed  CAS  Google Scholar 

  10. Milkiewicz P, Elias E, Williamson C, Weaver J: Obstetric cholestasis. BMJ 2002, 324:123–124.

    Article  PubMed  Google Scholar 

  11. Simon FR, Fortune J, Iwahashi M, et al.: Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1996, 271:G1043-G1052.

    PubMed  CAS  Google Scholar 

  12. Stieger B, Fattinger K, Madon J, et al.: Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (BSEP) of rat liver. Gastroenterology 2000, 118:422–430.

    Article  PubMed  CAS  Google Scholar 

  13. Sjövall J, Reyes H: Bile acids and progesterone metabolites in intrahepatic cholestasis of pregancy. Ann Med 2000, 32:94–106. Excellent summary of the current pathogenetic concepts and the role of hormonal factors in cholestasis of pregnancy, with particular reference to bile salt and progesterone metabolism.

    PubMed  Google Scholar 

  14. Bacq Y, Sapey T, Brechot MC, et al.: Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 1997, 26:358–364.

    Article  PubMed  CAS  Google Scholar 

  15. Eloranta ML, Heinonen S, Mononen T, Saarikoski S: Risk of obstetric cholestasis in sisters of index patients. Clin Genet 2001, 60:42–45.

    Article  PubMed  CAS  Google Scholar 

  16. Trauner M, Meier PJ, Boyer JL: Molecular pathogenesis of cholestasis. N Engl J Med 1998, 339:1217–1227.

    Article  PubMed  CAS  Google Scholar 

  17. Jacquemin E, Cresteil D, Manouvrier S, et al.: Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999, 353:210–211.

    Article  PubMed  CAS  Google Scholar 

  18. Dixon PH, Weerasekera N, Linton KJ, et al.: Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000, 9:1209–1217.

    Article  PubMed  CAS  Google Scholar 

  19. Simon E, Marschall HU, Glantz A, et al.: Mutations of hepatocanalicular ABC transporters in intrahepatic cholestasis of pregnancy (ICP). Hepatology 2002, 36:335A.

    Article  Google Scholar 

  20. Eloranta M, Heiskanen J, Hiltunen M, et al.: Multidrug resistance 3 gene mutation 1712delT and estrogen receptor alpha gene polymorphisms in Finnish women with obstetric cholestasis. Eur J Obstet Gynecol Reprod Biol 2002, 104:109–112, 132–135.

    Article  PubMed  CAS  Google Scholar 

  21. Rosmorduc O, Hermelin B, Poupon R: MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001, 120:1459–1467.

    Article  PubMed  CAS  Google Scholar 

  22. Kauppila A, Korpela H, Makila UM, Yrjanheikki E: Low serum selenium concentration and glutathione peroxidase activity in intrahepatic cholestasis of pregnancy. BMJ 1987, 294:150–152.

    Article  PubMed  CAS  Google Scholar 

  23. Reyes H, Báez ME, González MC, et al.: Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals in Chile. J Hepatol 2000, 32:542–549.

    Article  PubMed  CAS  Google Scholar 

  24. Jones EA, Bergasa NV: The pruritus of cholestasis. Hepatology 1999, 29:1003–1006.

    Article  PubMed  CAS  Google Scholar 

  25. Jenkins JK, Boothby LA: Treatment of itching associated with intrahepatic cholestasis of pregnancy. Ann Pharmacother 2002, 36:1462–1465.

    Article  PubMed  Google Scholar 

  26. Paumgartner G, Beuers U: Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002, 36:525–531. Authoritative review on molecular mechanisms of ursodeoxycholic acid for treatment of cholestatic disorders.

    Article  PubMed  CAS  Google Scholar 

  27. Palma J, Reyes JH, Ribalta J, et al.: Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. In In Bile Acids as Therapeutic Agents: From Basic Science to Clinical Practice. Edited by Paumgartner G, Stiehl A. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1991:319–322.

    Google Scholar 

  28. Palma J, Reyes H, Ribalta J, et al.: Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992, 15:1043–1047.

    Article  PubMed  CAS  Google Scholar 

  29. Marpeau L, Chazouilliere O, Rhimi Z, et al.: Pregnancyassociated idiopathic intrahepatic cholestasis. Hypotheses of physiopathology: a therapeutic case report. Fetal Diagn Ther 1991, 6:120–125.

    Article  PubMed  CAS  Google Scholar 

  30. Mazzella G, Rizzo N, Salzetta A, et al.: Management of intrahepatic cholestasis in pregnancy. Lancet 1991, 338:1594–1595.

    Article  PubMed  CAS  Google Scholar 

  31. Floreani A, Paternoster D, Grella V, et al.: Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1994, 101:64–65.

    PubMed  CAS  Google Scholar 

  32. Berkane N, Cocheton JJ, Brehier D, et al.: Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. A retrospective study of 19 cases. Acta Obstet Gynecol Scand 2000, 79:941–946.

    Article  PubMed  CAS  Google Scholar 

  33. Laifer SA, Stiller RJ, Siddiqui DS, et al.: Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 2001, 10:131–135.

    PubMed  CAS  Google Scholar 

  34. Diaferia A, Nicastri PL, Tartagni M, et al.: Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 1996, 52:133–140.

    Article  PubMed  CAS  Google Scholar 

  35. Floreani A, Paternoster D, Melis A, Grella PV: S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur J Obstet Gynecol Reprod Biol 1996, 67:109–113.

    Article  PubMed  CAS  Google Scholar 

  36. Palma J, Reyes H, Ribalta J, et al.: Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997, 27:1022–1028. Randomized placebo-controlled trial evaluating ursodeoxycholic for treatment of cholestasis of pregnancy.

    Article  PubMed  CAS  Google Scholar 

  37. Nicastri PL, Diaferia A, Tartagni M, Loizzi P, Fanelli M: A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1998, 105:1205–1207.

    PubMed  CAS  Google Scholar 

  38. Burrows RF, Clavisi O, Burrows E: Interventions for treating cholestasis in pregnancy (Cochrane review). In The Cochrane Library, Issue 3. Oxford, UK: Update Software; 2002.

    Google Scholar 

  39. Glantz A, Marschall HU, Lammert F, Mattsson LA: Intrahepatic cholestasis of pregnancy: a placebocontrolled randomised trial of ursodeoxycholic acid vs. dexamethasone on maternal and fetal outcome and metabolism. In Bile Acids: From Genomics to Disease and Therapy. Edited by Paumgartner G, Keppler D, Leuschner U, Stiehl A. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2003:252–259.

    Google Scholar 

  40. Mazzella G, Rizzo N, Azzaroli F, et al.: Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001, 33:504–508.

    Article  PubMed  CAS  Google Scholar 

  41. Brites D, Rodrigues CM, Oliveira N, et al.: Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J Hepatol 1998, 28:91–98.

    Article  PubMed  CAS  Google Scholar 

  42. Rust C, Sauter GH, Oswald M, et al.: Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man. Eur J Clin Invest 2000, 30:135–139.

    Article  PubMed  CAS  Google Scholar 

  43. Frezza M, Pozzato G, Chiesa L, et al.: Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-l-methionine administration. Hepatology 1984, 4:274–278.

    PubMed  CAS  Google Scholar 

  44. Frezza M, Centini G, Cammareri G, et al.: S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology 1990, 37(Suppl 2):122–125.

    PubMed  Google Scholar 

  45. Ribalta J, Reyes H, Gonzalez MC, et al.: S-adenosyl-lmethionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results. Hepatology 1991, 13:1084–1089.

    PubMed  CAS  Google Scholar 

  46. Lafuenti G, Plotti G, Nicolanti G, et al.: Valutazione delle modificazioni di parametri clinic e biochimic in gravide con colestasi in terapia con S-adenosyl-lmethionine per os. Giorn It Ost Gin 1988, 10:357–361.

    Google Scholar 

  47. Hirvioja ML, Tuimala R, Vuori J: The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gynaecol 1992, 99:109–111.

    PubMed  CAS  Google Scholar 

  48. Kretowicz E, McIntyre HD: Intrahepatic cholestasis of pregnancy, worsening after dexamethasone. Aust N Z J Obstet Gynaecol 1994, 34:211–213.

    PubMed  CAS  Google Scholar 

  49. Laatikainen T: Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy. Am J Obstet Gynecol 1978, 132:501–506.

    PubMed  CAS  Google Scholar 

  50. Shaw D, Frohlich J, Wittmann BA, Willms M: A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 1982, 142:621–625.

    PubMed  CAS  Google Scholar 

  51. Heikkinen J, Maentausta O, Ylostalo P, Janne O: Serum bile acid levels in intrahepatic cholestasis of pregnancy during treatment with phenobarbital or cholestyramine. Eur J Obstet Gynecol Reprod Biol 1982, 14:153–162.

    Article  PubMed  CAS  Google Scholar 

  52. Sadler LC, Lane M, North R: Severe fetal intracranial haemorrhage during treatment with cholestyramine for intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1995, 102:169–170.

    PubMed  CAS  Google Scholar 

  53. Karpen SJ: Nuclear receptor regulation of hepatic function. J Hepatol 2002, 36:832–850.

    Article  PubMed  CAS  Google Scholar 

  54. Espinoza J, Barnafi L, Schnaidt E: The effect of phenobarbital on intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 1974, 119:234–238.

    PubMed  CAS  Google Scholar 

  55. Nebert DW, Russell DW: Clinical importance of the cytochromes P450. Lancet 2002, 360:1155–1162.

    Article  PubMed  CAS  Google Scholar 

  56. Crowther CA, Henderson-Smart DJ: Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage (Cochrane review). In The Cochrance Library, Issue 2. Oxford, UK: Update Software; 2001.

    Google Scholar 

  57. Bothamley G: Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001, 24:553–565.

    Article  PubMed  CAS  Google Scholar 

  58. Gylling H, Riikonen S, Nikkila K, et al.: Oral guar gum treatment of intrahepatic cholestasis and pruritus in pregnant women: effects on serum cholestanol and other non-cholesterol sterols. Eur J Clin Invest 1998, 28:359–363.

    Article  PubMed  CAS  Google Scholar 

  59. Riikonen S, Savonius H, Gylling H, et al.: Oral guar gum, a gel-forming dietary fiber relieves pruritus in intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 2000, 79:260–264.

    Article  PubMed  CAS  Google Scholar 

  60. Kaaja RJ, Kontula KK, Raiha A, Laatikainen T: Treatment of cholestasis of pregnancy with peroral activated charcoal. A preliminary study. Scand J Gastroenterol 1994, 29:178–181.

    PubMed  CAS  Google Scholar 

  61. Gonzalez MC, Iglesias J, Tiribelli C, et al.: Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy. J Hepatol 1992, 16:241–242.

    Article  PubMed  CAS  Google Scholar 

  62. Fisk NM, Storey GN: Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988, 95:1137–1143.

    PubMed  CAS  Google Scholar 

  63. Roncaglia N, Arreghini A, Locatelli A, et al.: Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 2002, 100:167–170.

    Article  PubMed  Google Scholar 

  64. Heinonen S, Kirkinen P: Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 1999, 94:189–193.

    Article  PubMed  CAS  Google Scholar 

  65. Kenyon AP, Piercy CN, Girling J, et al.: Obstetric cholestasis, outcome with active management: a series of 70 cases. Br J Obstet Gynaecol 2002, 109:282–288.

    Google Scholar 

  66. Glasinovic JC, Valdivieso V, Covarrubias C, et al.: Pregnancy and gallstones. In Pregnancy, Sex Hormones and the Liver. Edited by Reyes HB, Leuschner U, Arias IM. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1996:267–281.

    Google Scholar 

  67. Lanzafame RJ: Laparoscopic cholecystectomy during pregnancy. Surgery 1995, 118:627–631.

    Article  PubMed  CAS  Google Scholar 

  68. Graham G, Baxi L, Tharakan T: Laparoscopic cholecystectomy during pregnancy: a case series and review of the literature. Obstet Gynecol Surg 1998, 53:566–574.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine III, University Hospital Aachen (UKA), Aachen University (RWTH), Pauwelsstrasse 30, 52057, Aachen, Germany

    Frank Lammert MD, Hanns-Ulrich Marschall MD, PhD & Siegfried Matern MD

Authors
  1. Frank Lammert MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanns-Ulrich Marschall MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Siegfried Matern MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lammert, F., Marschall, HU. & Matern, S. Intrahepatic cholestasis of pregnancy. Curr Treat Options Gastro 6, 123–132 (2003). https://doi.org/10.1007/s11938-003-0013-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-003-0013-x

Keywords

Search

Navigation